CAPA - The Standards Navigator

How to Audit a Medical Device QMS: The ISO 13485 Internal Audit Process (2026 Guide)

This guide walks medical device manufacturers through the ISO 13485 Clause 8.2.4 internal audit requirement — including audit program design, the six-step audit process, and the five most common findings auditors cite. It also covers what changed under the FDA QMSR and the new ISO 19011:2026 audit guidance.

A clause-by-clause guide to planning, conducting, and closing out ISO 13485 internal audits under the new FDA QMSR

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

The Internal Audit That Used to Be Private Isn’t Anymore

For years, medical device manufacturers treated the internal audit report as an internal document — useful for finding problems, but shielded from FDA inspectors under the confidentiality provision in the old 21 CFR 820.180(c). That protection is gone.

Since February 2, 2026, the FDA’s Quality Management System Regulation (QMSR) has been in effect, and it incorporates ISO 13485:2016 by reference rather than running a parallel U.S.-specific standard alongside it. FDA’s own Final Rule FAQ is direct about what that means for audits: “The QMSR gives the FDA the authority to inspect management review, quality audits, and supplier audit reports. The exceptions that existed in the QS regulation at § 820.180(c) are not maintained in the QMSR.” That’s not a third-party interpretation — it’s FDA’s own published position.

So this isn’t limited to internal audit reports. Management review minutes and supplier audit reports lost the same protection. A checklist you run through once a year to satisfy Clause 8.2.4 on paper is no longer a low-risk approach — it’s now a document an inspector may read line by line, and so are the meetings where leadership reviewed it.

From the Floor: I’ve built and run internal audit programs at facilities with 500-plus employees, and the finding that costs organizations the most isn’t a missing procedure — it’s a corrective action that gets closed on paper before the root cause is actually fixed. As a certified ISO 9001 Internal Auditor, I’ve sat across the table from auditors who catch that in about ninety seconds. Whether you’re auditing to ISO 9001 or ISO 13485, the internal audit only works if it’s harder on you than the external one will be.

Before your next surveillance audit, most quality teams don’t fail because they misunderstand Clause 8.2.4 — they fail because their audit program looks complete on paper but hasn’t been stress-tested against real objective evidence. Run your QMS through the free ISO 13485 Gap Assessment Checklist before an inspector or a Notified Body does it for you.

In This Guide

What ISO 13485 Clause 8.2.4 actually requires
How internal audits differ from supplier and certification audits
What Clause 6.2 actually requires of your auditors — and what “competent” really means
Building a risk-based annual audit program
The audit process: planning, evidence, reporting, and CAPA follow-up
A real finding-to-CAPA example, start to finish
The five most common internal audit findings — and how to avoid them
What changes if you’re audited under MDSAP
What changed under the FDA QMSR and ISO 19011:2026
Whether you need outside help or can run this internally

👉 Start Here (Top Resources)

9001Simplified — Build Your Audit Program Without a Consultant — documentation and procedure templates you can adapt for a Clause 8.2.4 internal audit program without hiring outside help.
ISO 13485:2016 — ANSI Webstore — the official standard, which every internal audit checklist should be built against directly, not from a secondhand summary. Use code CC2026 for 5% off your order through December 31, 2026.
ISO 13485 Training — BSI Group — formal internal auditor training if you need documented Clause 6.2 competence records for your audit team.

What Clause 8.2.4 Actually Requires

ISO 13485 requires internal audits under Clause 8.2.4 to verify that QMS processes are implemented and effective, catch nonconformities, and surface QMS deficiencies early enough that they don’t become product-safety or regulatory problems. That sounds close to ISO 9001’s internal audit clause, and it is — but ISO 13485 asks for more.

Clause 8.2.4 requires that internal audits determine conformity to planned arrangements, the requirements of the standard, the organization’s own QMS requirements, and applicable regulatory requirements — and unlike ISO 9001, ISO 13485 explicitly requires the audit program to account for regulatory requirements such as FDA 21 CFR Part 820, EU MDR, or MDSAP alongside the standard itself. Teams that build their audit program purely off the ISO 13485 clause structure, without folding in the regulatory layer, are the ones who get flagged.

Most common finding: auditors treat Clause 8.2.4 as a documentation-review exercise and skip the regulatory cross-reference entirely. If your audit checklist doesn’t ask “does this also satisfy 21 CFR Part 820 or MDR Article 10?” it isn’t finished.

Audits must assess conformity across critical processes — design and development under Clause 7.3, corrective action under Clause 8.5.2, preventive action under Clause 8.5.3, production under Clause 7.5, and document control under Clause 4.2 — using objective evidence like device history records, audit trails, and validation records. Auditors must be trained, qualified, and independent of the area they’re auditing, with that competence documented under Clause 6.2.

If you are already ISO 9001 certified → your internal audit infrastructure transfers directly, but your checklist needs a regulatory column added for every process area, not just a conformity column.

Internal Audits vs. Supplier Audits vs. Certification Audits

Comparison infographic showing internal audits, supplier audits, and certification audits under ISO 13485. — Understanding the differences between internal, supplier, and certification audits improves audit planning and regulatory compliance.

Manufacturers frequently conflate these three, and an auditor will notice immediately if your procedure does too.

Audit Type	Governing Clause	Performed By	Primary Purpose
Internal Audit	Clause 8.2.4	Trained internal personnel, independent of the area audited	Verify your own QMS conforms to the standard and your own procedures
Supplier Audit	Clause 7.4.1	Quality or supplier quality personnel	Verify external providers meet quality and regulatory requirements
Certification Audit	ISO/IEC 17021-1	Accredited third-party Notified Body or registrar	Determine whether the full QMS meets ISO 13485 for certification

ISO 13485 requires internal audits, just as its sister standard ISO 9001 does, and they exist for two reasons: to confirm the QMS meets the standard’s requirements, and to confirm the organization actually follows its own rules. A strong internal audit program is what makes a certification audit uneventful instead of a fire drill.

Auditor Competence: What Clause 6.2 Actually Requires

This is the section most audit programs get thin on, and it’s where a surprising number of otherwise solid internal audit programs fall apart under scrutiny.

Clause 6.2 requires that anyone doing work affecting product quality — and that includes auditors — be competent based on appropriate education, training, skills, and experience. ISO 13485 doesn’t spell out a fixed list of required knowledge areas the way a checklist would, but three areas consistently show up when a Notified Body reviews auditor files:

The standard itself. A working knowledge of ISO 13485:2016 clause structure, not just the SOPs written to satisfy it.
Audit methodology. Understanding of the audit cycle — planning, evidence gathering, reporting, follow-up — along with the difference between a minor observation and a major nonconformity. ISO 13485’s own note under Clause 8.2.4 points auditors toward ISO 19011 for this.
Applicable regulatory context. Basic familiarity with the regulations that apply to your product and markets — 21 CFR Part 820, EU MDR, MDSAP — not full legal mastery, but enough to recognize when a finding also touches a regulatory requirement.

Competence is not the same thing as certification. ISO 13485 does not require a certified internal auditor credential, and ISO 19011 doesn’t mandate formal training either — the standard’s actual requirement is that the audit process ensure objectivity and impartiality, and that competence be evaluated and documented. In practice, though, “read and understand the internal procedure” is not evidence Notified Bodies accept as sufficient. An auditor who can’t produce a training record, a completed course certificate, or documented on-the-job evaluation showing how their competence was assessed is a finding waiting to happen — even if that person is, in fact, good at the job.

What acceptable training records look like in practice:

A certificate of completion from an ISO 13485 internal auditor course (typically covering the standard itself plus ISO 19011 audit methodology) — see BSI vs. ISOQAR if you’re deciding where to send your team for that training
Internal on-the-job qualification records — a documented mentored audit or two, signed off by a qualified lead auditor
A training matrix that ties each auditor to the specific processes and clauses they’re qualified to audit, refreshed when the QMS or the standard changes

Auditor independence gets checked alongside competence. The most frequent failure here isn’t a skills gap — it’s a quality manager who owns a process auditing that same process, or an auditor rotation that never actually rotates the highest-risk areas like design controls.

If you are not confident your auditor files would hold up to this list → that’s a fifteen-minute file review, not a project, and it’s worth doing before your next Notified Body visit rather than during it.

Building a Risk-Based Audit Program

The audit program must cover every process, department, and site within your QMS scope, with audit frequency determined by the status and importance of each process along with the results of prior audits. High-risk processes — design and development, production, CAPA, and complaint handling — typically need at least annual coverage, while lower-risk support functions can be audited less frequently if previous results were consistently clean.

Most manufacturers get the frequency question backwards. They audit everything on a flat annual calendar instead of weighting toward where the last audit found something. If your CAPA process had a finding last year, auditing it again on the same twelve-month clock as your HR training records is a scheduling decision an inspector will question.

If you are preparing for your first surveillance audit under the new QMSR → build your program around the regulatory cross-reference first, then layer the standard’s clause structure on top of it — not the other way around.

The Internal Audit Process, Step by Step

Infographic illustrating the ISO 13485 internal audit process from planning through CAPA verification for medical device quality management systems. — The six-step ISO 13485 internal audit process helps medical device manufacturers identify nonconformities and verify corrective actions.

Prepare a checklist based on the relevant clauses of ISO 13485, your documented procedures, and applicable regulatory requirements — a good checklist prompts investigation rather than simply confirming what’s already assumed to be true.

1. Scope and schedule. Define which processes, sites, and clauses are in scope for this audit cycle.

2. Documentation review. Analyze the quality manual, procedures, and prior audit reports before setting foot on the floor — this is where checklists get mapped to specific clauses.

3. Opening meeting. Confirm scope, objectives, and methodology with the auditee before evidence-gathering begins — this sets the tone for the entire audit.

4. Evidence gathering. Collect objective evidence through interviews, direct observation, and document/record review — no finding should be written down without evidence behind it.

5. Reporting. Findings get written up, classified by severity, and routed to the process owner and management.

6. CAPA follow-up. Every corrective action needs documented root cause analysis appropriate to the significance of the nonconformity, with effectiveness verified before the CAPA is closed.

Most teams execute steps 1 through 5 competently. Step 6 is where programs fall apart — a CAPA gets marked closed the day the immediate fix is implemented, with no verification that the fix actually held.

Trigger: If your last three internal audits found the same category of nonconformity in different words each time, that’s not three separate findings — that’s one root cause your CAPA process never actually reached.

Before your next audit cycle, check your CAPA closure process against what auditors actually verify — most teams don’t realize how thin their effectiveness checks are until someone else reviews them.

A Real Finding, Start to Finish

Steps on a page are easy to nod along with. Here’s what a properly closed finding actually looks like end to end, using one of the most common design-control gaps auditors find.

Stage	What It Looked Like
Finding	During a design and development audit, three of twelve design verification records sampled were missing the reviewer’s signature. Work was completed and dated, but sign-off wasn’t captured.
Objective Evidence	Design History File records DHF-114, DHF-119, and DHF-122, cross-referenced against the design review meeting minutes showing the reviews occurred.
Nonconformity Statement	“Design verification records DHF-114, DHF-119, and DHF-122 lack the required reviewer signature per QMS-SOP-014, Section 6.2. Design and development control per ISO 13485:2016 Clause 7.3.6 requires verification results, including necessary actions, to be recorded.”
Root Cause	Investigation traced it to a recent SOP revision that moved the sign-off step later in the workflow. Staff hadn’t been retrained on the updated sequence — the procedure changed, but the training that should have accompanied it under Clause 6.2 didn’t happen.
Correction	The three records were completed retroactively with the reviewer’s signature and a note explaining the delay, reviewed and accepted by the quality manager.
Corrective Action (CAPA)	Retrain design team on the revised sign-off sequence; add a mandatory signature field to the design review template so records can’t be filed incomplete.
Effectiveness Check	Sample the next ten design verification records over the following quarter. Zero missing signatures required to close the CAPA as effective.

Notice what makes this closeable rather than cosmetic: the root cause isn’t “people forgot” — it’s a training gap tied to a specific procedure change, and the corrective action addresses the system, not just the three records. That’s the difference between a finding that stays closed and one that reappears with different reference numbers next year.

The Five Most Common Findings

Infographic highlighting the five most common ISO 13485 internal audit findings in medical device quality management systems. — The most common ISO 13485 internal audit findings often involve documentation, CAPA effectiveness, auditor competence, and risk-based planning.

Incomplete audit records — missing reports, plans, or linked CAPAs — is one of the most frequently cited internal audit issues. A close second is failing to apply a risk-based approach to audit planning, or simply not maintaining the internal audit schedule at all. Beyond that, auditors regularly find no timely follow-up on actions from internal audits, no records showing auditor competence against the applicable regulations, and auditors who weren’t actually impartial — reviewing work they had a hand in.

Design and development controls remain the single most frequently cited nonconformity area globally — incomplete design inputs, missing verification or validation records, undocumented design changes, or no formal design transfer procedure. See Validation & Verification Requirements for how this plays out in practice.

⚠️ If your auditor rotation lets the same person audit design controls year after year without ever being audited themselves on that same process, that’s an impartiality gap that a Notified Body will flag before you do.

If you are not confident your last internal audit would hold up under this list → that’s exactly what a structured gap assessment is for, not a guess.

Check your program against these five findings before your next audit — most gaps take under 45 minutes to identify →

MDSAP: What Changes for Multi-Market Audits

If your devices sell into more than one of the five MDSAP markets — the U.S., Canada, Australia, Brazil, or Japan — your internal audit program needs to account for a different audit model, not just an extra regulatory reference.

The Medical Device Single Audit Program lets one audit by an accredited Auditing Organization satisfy the requirements of all five participating regulators at once, in place of separate national audits. It’s built on ISO 13485:2016, but it isn’t a straight overlay — MDSAP uses a process-based audit model with a defined sequence, rather than working straight down the ISO clause list, and it maps every audit task to both the relevant ISO 13485 clause and each country’s specific regulatory requirement.

The grading system is the biggest practical difference. Where an ISO 13485 certification audit typically classifies findings as minor or major, MDSAP uses a points-based Grade 1–5 scale: nonconformities affecting clauses with indirect QMS impact start lower, direct-impact clauses start higher, and points are added for repeat findings or for a nonconforming product that was actually released. Grade 4 and 5 findings must be resolved before a certificate is issued or maintained — there’s no ambiguity about severity once the math is run.

What this means for your internal audit program: if you’re pursuing or maintaining MDSAP, your internal audits should follow the MDSAP process sequence — not just walk through ISO 13485 clauses in order — so that gaps surface in the same structure an Auditing Organization will use. The recurring findings across published MDSAP audits track closely with the same weak points internal audits should already be hunting for: open CAPAs left unclosed past a reasonable window, supplier and purchasing controls that don’t demonstrate follow-through, and root cause analysis that’s thin enough to not survive a second look.

One benefit worth knowing about: MDSAP audit reports can substitute for the FDA’s routine biennial device inspections. A well-run MDSAP program isn’t just multi-market efficiency — it can reduce how often FDA shows up separately.

What Changed: QMSR and ISO 19011:2026

Two regulatory shifts affect how internal audits get run in 2026, and both are recent enough that older internal procedures may not reflect them.

Since February 2, 2026, the FDA’s QMSR has incorporated ISO 13485:2016 by reference, replacing the former Quality System Regulation, and FDA inspections now run under Compliance Program 7382.850 rather than the old QSR framework. As covered above, the practical effect for internal audits is direct: the confidentiality safe harbor that used to apply to internal audit reports, management review records, and supplier audit reports under the old 21 CFR 820.180(c) has been removed, and FDA’s own FAQ confirms it in plain language.

Separately, ISO published the fourth edition of ISO 19011 — Guidelines for auditing management systems — on May 27, 2026, replacing the 2018 edition that had guided audit programs for nearly eight years. ISO 13485 doesn’t mandate ISO 19011 compliance directly — Clause 8.2.4 references audit principles in its own language — but Notified Bodies and experienced auditors widely treat ISO 19011 as the authoritative reference for structuring an audit program, so if your internal audit SOPs still cite the 2018 edition, expect your Notified Body to ask why.

Neither change requires rebuilding your program from scratch. Both are reasons to review your internal audit SOP this year rather than next.

Quick Audit-Readiness Checklist

✅ Audit program covers every process, site, and department in your QMS scope ✅ Audit frequency is risk-weighted, not a flat annual calendar
✅ Every checklist item maps to a specific ISO 13485 clause and the applicable regulatory requirement
✅ Auditors are independent of the area they’re reviewing, with Clause 6.2 competence records on file — not just “read and understand” sign-offs
✅ Findings are backed by objective evidence — interviews, observation, or documented records
✅ CAPA effectiveness is verified before closure, not assumed
✅ If pursuing MDSAP, internal audits follow the MDSAP process sequence, not just the ISO clause order
✅ Internal audit SOP references ISO 19011:2026, not the 2018 edition
✅ Design and development records are current — this is the single most-cited finding category

FAQ

How often does ISO 13485 require internal audits?

The standard doesn’t specify a fixed interval — it requires audits “at planned intervals” based on process risk and prior audit history. Most manufacturers audit high-risk processes like design controls and CAPA annually at minimum, with lower-risk support functions audited less frequently if history is clean.

Can the same person who performs a process also audit it?

No. Clause 8.2.4 requires auditors to be independent of the area being audited. A quality manager who owns the CAPA process, for example, shouldn’t be the one auditing CAPA compliance.

Do internal auditors need a formal certification?

No. ISO 13485 requires documented competence — education, training, skills, and experience — but doesn’t mandate a specific certification. In practice, most Notified Bodies expect more than an internal read-and-understand sign-off, so a course certificate or documented mentored-audit record is the safer standard to work toward.

Does the FDA QMSR require a separate internal audit program from ISO 13485?

No. Since the QMSR incorporates ISO 13485:2016 by reference, there isn’t a separate U.S.-specific internal audit requirement layered on top — your Clause 8.2.4 program is the audit program the FDA now expects, with the regulatory cross-reference built in.

Are internal audit reports confidential from FDA inspectors?

Not anymore. FDA’s own QMSR Final Rule FAQ confirms the confidentiality exceptions under the old 21 CFR 820.180(c) — covering internal audits, management review, and supplier audits — are not maintained under the QMSR.

What’s the difference between an internal audit and a supplier audit under ISO 13485?

Internal audits (Clause 8.2.4) evaluate your own QMS. Supplier audits (Clause 7.4.1) evaluate external providers’ ability to meet your quality and regulatory requirements. Both are required, but they’re separate programs with separate scopes.

Does MDSAP replace our ISO 13485 internal audit requirement?

No, but it changes the structure. MDSAP is built on ISO 13485 and layers in country-specific regulatory requirements from up to five markets, using a process-based sequence and a points-based Grade 1–5 nonconformity system rather than the minor/major classification used in standard certification audits.

What’s the most common reason internal audit programs fail a certification audit?

Incomplete records — missing audit reports, plans, or linked CAPAs — combined with no evidence of a risk-based approach to scheduling. Both are findings a Notified Body catches quickly because they’re procedural gaps, not technical ones.

Should we hire a consultant to run our internal audits, or can we do it ourselves?

Either can work if the auditor is properly trained and genuinely independent of the process. Many manufacturers use in-house auditors for most cycles and bring in an outside auditor periodically to test whether their internal program is actually rigorous or just familiar with its own blind spots.

📥 Free Resources

ISO 9001 Roadmap — step-by-step implementation guide for manufacturers building or improving a quality management system
Manufacturing Compliance Checklist — practical compliance reference covering key ISO, OSHA, and quality requirements for production environments
Supplier Quality Checklist — evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts
ISO 13485 Gap Assessment Checklist — free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements
AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification

Not Sure What to Do Next?

🔹 Still researching your audit obligations? Start with ISO 13485 Documentation Requirements to understand what your QMS needs on paper before you audit it.

🔹 Ready to build or strengthen your audit program? 9001Simplified’s documentation templates can shortcut the SOP-writing process without a consultant retainer.

🔹 Need the standard itself to build your checklist against? Get ISO 13485:2016 from ANSI Webstore — code CC2026 takes 5% off through the end of 2026.

An internal audit program that only exists to satisfy Clause 8.2.4 on paper was already a risk before the QMSR removed the confidentiality safe harbor. Now it’s a document an inspector can read directly. The Standards Navigator will keep tracking what QMSR enforcement and ISO 19011:2026 mean for how medical device manufacturers actually run their audit programs — not just what the clause says.

Most manufacturers don’t lose a certification over one bad audit finding — they lose it over a pattern of findings their own internal audit program should have caught first. Organizations that treat Clause 8.2.4 as a paperwork requirement get surprised at surveillance. Organizations that treat it as their first line of defense rarely do.

The Standards Navigator tracks how ISO 13485, the FDA QMSR, and the standards that govern medical device audits actually work in practice — not just what the clause text says.

👉 Get updates on ISO 13485 audit requirements and QMSR enforcement changes 👉 Be first to access new medical device compliance checklists and gap assessment tools

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

Medical Device Compliance Standards: What Manufacturers Need to Know in 2026

Medical device manufacturers face a layered compliance framework — ISO 13485, ISO 14971, FDA QMSR, and EU MDR each impose specific requirements that must work together as an integrated system. This guide explains the core standards, how they interact, and what manufacturers need to prioritize at each stage of the compliance process.

The regulatory framework every medical device manufacturer must understand before the first audit

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

The Compliance Gap That Gets Medical Device Manufacturers in Trouble

Most medical device manufacturers don’t fail audits because they ignored the requirements. They fail because they didn’t understand how the requirements connect — and which standards they were actually obligated to meet.

The medical device compliance standards landscape is layered. ISO 13485 sets the QMS framework. ISO 14971 governs risk management. FDA regulations run parallel to international standards and don’t always align. Supplier controls, sterilization validation, design controls, and labeling each carry their own standard reference. A manufacturer who treats these as independent checkboxes instead of an integrated system is building toward an audit finding — or worse, a product recall.

The stakes are not abstract. The FDA issued 483 observations totaling thousands of findings in the medical device sector last year. Most cited documentation gaps, inadequate CAPA processes, or failure to meet design control requirements — all areas governed by the standards covered in this guide.

I’ve worked in quality systems that span heavy industrial, energy, and manufacturing environments — and the pattern I’ve seen across every sector is the same: organizations that struggle with audits are usually managing compliance requirements in silos. In the medical device world, that problem is amplified because the regulatory framework is both more complex and less forgiving than most industrial standards. Getting the structure right before your first audit is not optional — it’s the difference between certification and a warning letter.

Before you map your compliance requirements, download the ISO 13485 Gap Assessment Checklist — it walks you through every clause so you can identify exactly where your QMS falls short before an auditor does → ISO 13485 Gap Assessment Checklist

In This Guide:

The core standards every medical device manufacturer must know
How ISO 13485, ISO 14971, and FDA regulations interact
US vs. EU regulatory requirements compared
Supplier control and special process standards
Decision-stage guidance: what to prioritize based on where you are in the compliance process

👉 Start Here — Top Resources

Buy ISO 13485:2016 — ANSI Webstore — the official QMS standard for medical device manufacturers (use code CC2026 for 5% off)
ISO 13485 Training — BSI Group — training courses and certification services for ISO 13485
Buy ISO 14971:2019 — ANSI Webstore — risk management standard required alongside ISO 13485

The Core Standard: ISO 13485:2016

ISO 13485:2016 infographic showing clause structure and comparison of ISO 13485 versus ISO 9001 requirements for medical device quality management systems. — A visual breakdown of ISO 13485:2016 requirements and how they differ from ISO 9001 for medical device manufacturers.

ISO 13485:2016 is the international standard for quality management systems specific to medical device manufacturers and their supply chains. It is the foundation of medical device compliance worldwide.

ISO 13485 is not simply ISO 9001 with medical device language added. The two standards share structural similarities through the harmonized high-level clause structure, but ISO 13485 imposes stricter requirements in several critical areas ISO 9001 leaves to organizational discretion:

Requirement Area	ISO 9001:2015	ISO 13485:2016
Risk management	Risk-based thinking (general)	Formal risk management required (links to ISO 14971)
Design controls	Required	More prescriptive — validation, verification, design transfer
CAPA	Required	More detailed — specific investigation and effectiveness checks
Regulatory requirements	Not addressed	Explicitly required — must identify and meet applicable regs
Sterile product controls	Not addressed	Specific controls for sterile devices
Supplier controls	Required	More stringent — supplier qualification and monitoring
Document and record retention	Not specified	Specific retention periods tied to device lifetime

If you are ISO 9001 certified and entering the medical device market, you are not starting from scratch — but you are adding significant requirements. The gap is larger than most manufacturers expect.

If you need the standard itself, ISO 13485:2016 is available through the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026.

Most common finding: Inadequate document control — specifically, failure to control the review and approval of documents and maintain records of changes. ISO 13485 Clause 4.2 is one of the most frequently cited areas in FDA 483 observations.

Risk Management: ISO 14971:2019

ISO 14971 is the international standard for risk management applied to medical devices. It is not optional if you are manufacturing medical devices — ISO 13485 explicitly requires you to apply risk management throughout the product lifecycle, and ISO 14971 is the recognized method for doing it.

ISO 14971:2019 defines the process for:

Identifying hazards associated with a medical device
Estimating and evaluating associated risks
Controlling those risks
Monitoring the effectiveness of controls

The relationship between ISO 13485 and ISO 14971 is not optional. ISO 13485 Clause 7.1 requires organizations to establish risk management requirements for product realization. ISO 14971 is the standard that defines what “proper” risk management looks like. Auditors will look for evidence that your risk management file connects directly to your design controls, production processes, and post-market surveillance activities.

ISO 14971 vs. ISO 13485 — understanding how they interact is one of the most common questions from manufacturers building a QMS for the first time.

If your risk management files exist independently of your design control documentation — that is an audit finding waiting to happen. Most teams miss the linkage between hazard identification in the risk management file and the verification/validation activities in the design history file.

Run your gap assessment before you go further — most QMS gaps in medical device companies trace back to missing connections between ISO 14971 risk files and ISO 13485 design controls: ISO 13485 Gap Assessment Checklist

US Regulatory Requirements: FDA QMSR and 21 CFR Part 820

US medical device manufacturers operate under FDA jurisdiction. The Quality Management System Regulation (QMSR), which took effect February 2, 2026, replaced the legacy Quality System Regulation (QSR) under 21 CFR Part 820.

The QMSR represents a significant shift: it incorporates ISO 13485:2016 by reference as the baseline for device QMS requirements. This means FDA-regulated manufacturers who are ISO 13485 certified are closer to QMSR compliance than they were under the old QSR — but important differences remain.

Area	ISO 13485:2016	FDA QMSR (2026)
Scope	International	US market devices only
Complaints	Required	Required + specific MDR reporting timelines
Corrections and removals	Addressed in CAPA	Specific FDA reporting requirements (21 CFR Part 806)
UDI	Not addressed	Required for most device classes
Electronic records	Not specified	21 CFR Part 11 compliance required
Third-party audits	Required for ISO 13485 certification	FDA inspections — not third-party certification

Understanding the relationship between FDA QSR and ISO 13485 is essential for US manufacturers — the two frameworks are now more aligned than before, but they are not identical.

If you are selling devices in the US market, FDA QMSR compliance is a legal requirement, not a voluntary certification. ISO 13485 certification does not satisfy FDA obligations — it demonstrates QMS capability but does not substitute for an FDA inspection.

Comparison infographic showing US FDA QMSR and EU MDR regulatory pathways for medical device manufacturers and ISO 13485 quality system requirements. — A side-by-side comparison of US FDA QMSR and EU MDR pathways showing how medical device compliance differs across global markets.

EU Requirements: MDR and CE Marking

Selling medical devices in the European Union requires CE marking under the EU Medical Device Regulation (MDR 2017/745), which replaced the Medical Device Directive (MDD) and came into full effect in 2021. The transition deadline for legacy MDD-certified devices has been extended but enforcement has tightened significantly.

Key MDR requirements relevant to QMS:

MDR Requirement	Connection to ISO 13485
Technical documentation	Design history file / DHF requirements
Clinical evaluation	Post-market clinical follow-up (PMCF)
Unique Device Identification (UDI)	Traceability requirements
Post-market surveillance (PMS)	Customer feedback and complaint monitoring
Notified Body audit	ISO 13485 certification is typically required
Person Responsible for Regulatory Compliance (PRRC)	Management responsibility — ISO 13485 Clause 5

The MDR is more prescriptive than ISO 13485 in clinical evidence requirements. If you are exporting to the EU, your clinical evaluation report and post-market surveillance plan must meet MDR requirements that go beyond what ISO 13485 explicitly requires.

If you are selling in both the US and EU markets, you are managing two regulatory frameworks simultaneously. This is where a well-structured ISO 13485 QMS becomes particularly valuable — it provides the common foundation that both frameworks build on.

Supplier Controls and Special Process Standards

ISO 13485 Clause 7.4 imposes stricter supplier control requirements than most manufacturers new to the medical device space expect. You are not simply verifying that a supplier has a quality system — you are responsible for ensuring that purchased products and services meet specified requirements and that critical suppliers are evaluated, approved, and monitored.

For medical device manufacturers, supplier controls must address:

Supplier qualification — documented criteria for evaluation and approval
Incoming inspection — defined acceptance criteria for purchased product
Critical supplier monitoring — ongoing performance data, not just initial qualification
Supplier audits — for high-risk or critical component suppliers
Flow-down requirements — pushing your quality requirements into the supply chain

Special processes — sterilization, biocompatibility testing, coating, welding on implantable components — require additional validation documentation. The relevant standards include:

Process	Standard Reference
Sterilization (EO, radiation, steam)	ISO 11135, ISO 11137, ISO 17665
Biocompatibility	ISO 10993 series
Packaging validation	ASTM F2132, ISO 11607
Software validation	IEC 62304
Electrical safety	IEC 60601 series

These are not optional for manufacturers of the relevant device types. If your device is sterilized, you need sterilization validation documentation. If it contacts patient tissue, you need biocompatibility data. Gaps in special process validation are among the most serious findings an FDA inspector or Notified Body auditor can cite.

Design Controls and Validation Standards

ISO 13485 design controls infographic showing the Design History File process from inputs through outputs, verification, validation, and design transfer. — A visual guide to the ISO 13485 design controls process and how design inputs become validated, production-ready medical devices.

Design controls are where ISO 13485 certification and FDA compliance intersect most directly. ISO 13485 Clause 7.3 requires a structured design and development process covering:

Design and development planning
Design inputs (requirements)
Design outputs (specifications)
Design review at defined stages
Design verification (does it meet inputs?)
Design validation (does it meet user needs?)
Design transfer (can it be manufactured consistently?)
Design changes (controlled and documented)

The design history file (DHF) is the physical record of this entire process. It is the first thing an FDA inspector or Notified Body auditor will request. Manufacturers who build their DHF as a collection of unconnected documents — rather than as a traceable record linking inputs to outputs to verification to validation — create significant risk for themselves.

If you are new to building a medical device QMS and need a structured path through these requirements, the ISO 13485 Implementation Roadmap on The Standards Navigator covers the full sequence from gap assessment through certification.

BSI Group offers ISO 13485 training covering both requirements understanding and implementation — useful for teams building their first medical device QMS or transitioning from a general ISO 9001 system.

Labeling and Traceability Standards

Labeling compliance is a specific, frequently cited area in FDA 483 observations. Under both FDA QMSR and MDR requirements, device labeling must meet defined content and format requirements — and the label must be controlled as a quality record.

Key labeling standards and requirements:

ISO 15223-1 — symbols used in medical device labeling (required for EU MDR compliance)
21 CFR Part 801 — FDA labeling requirements for US devices
UDI requirements — FDA requires Unique Device Identification on most device labels, with submission to the GUDID database

Traceability connects directly to your CAPA and complaint handling processes. If a complaint involves a specific lot or device unit, your traceability records must be sufficient to identify affected products, investigate the root cause, and determine corrective action scope. ISO 13485 Clause 7.5.9 addresses traceability explicitly — and auditors will test it.

How the Standards Work Together

Layered medical device compliance standards infographic showing ISO 13485 as the foundation with ISO 14971, FDA QMSR, EU MDR, supplier controls, CAPA, and traceability requirements. — A visual framework showing how ISO 13485, FDA QMSR, EU MDR, and supporting standards connect into an integrated medical device compliance system.

The most important thing to understand about medical device compliance is that these standards are not independent — they form an integrated system. Here is how they connect:

Standard	Role in the System
ISO 13485:2016	QMS framework — the backbone that everything else connects to
ISO 14971:2019	Risk management process — required by ISO 13485, referenced throughout
FDA QMSR	US regulatory layer — builds on ISO 13485, adds FDA-specific requirements
EU MDR	EU regulatory layer — requires ISO 13485 certification via Notified Body
IEC 62304	Software lifecycle — required if your device includes software
ISO 10993	Biocompatibility — required for patient-contacting devices
ISO 15223	Labeling symbols — required for EU MDR labeling compliance

A manufacturer who has ISO 13485 certification, a complete ISO 14971 risk management file, and solid FDA QMSR documentation has built the framework that all additional standards layer onto. The common mistake is treating each standard as a separate compliance project rather than building the integrated system first.

If you are deciding between prioritizing FDA QMSR or ISO 13485 certification first: in most cases, building to ISO 13485 gives you the QMS foundation that both US and EU regulatory compliance require. The ISO 13485 Documentation Requirements article covers what your QMS documentation set must include.

Quick Compliance Checklist

Use this as a starting reference — not a substitute for a clause-by-clause gap assessment.

✅ ISO 13485:2016 obtained and QMS scope defined
✅ Risk management procedure in place referencing ISO 14971
✅ Design controls documented — inputs, outputs, verification, validation, transfer
✅ CAPA process established with effectiveness verification
✅ Supplier qualification and monitoring program documented
✅ Document and record control procedures in place with defined retention periods
✅ Internal audit program scheduled and resourced
✅ Management review process defined and conducted
✅ Complaint handling and MDR/vigilance reporting process established
✅ UDI requirements evaluated and implemented where applicable
✅ Applicable special process validations identified and documented
✅ Labeling reviewed against ISO 15223 (EU) and 21 CFR Part 801 (US)

⚠️ If you cannot check most of these — complete a formal gap assessment before committing to a certification timeline.

FAQ

Is ISO 13485 certification required to sell medical devices?

ISO 13485 certification is not legally required by US law — the FDA requires QMSR compliance, not ISO 13485 certification specifically. However, ISO 13485 certification is required to sell devices in the EU under MDR, and it is increasingly required by OEM customers and contract manufacturers as a condition of doing business. Most manufacturers targeting both markets pursue certification.

How is ISO 13485 different from ISO 9001?

ISO 13485 is a sector-specific standard derived from ISO 9001 but with significantly stricter requirements in risk management, design controls, CAPA, supplier controls, and regulatory compliance. It does not include the continual improvement emphasis that ISO 9001 requires — instead it focuses on consistent compliance with regulatory requirements. A detailed comparison is covered here.

Do I need ISO 14971 if I am ISO 13485 certified?

Yes. ISO 13485 explicitly requires risk management throughout the product lifecycle and references ISO 14971 as the applicable method. You are not ISO 13485 compliant if your risk management process does not meet ISO 14971 requirements. The two standards work together — you cannot separate them.

What is the FDA QMSR and how is it different from the old QSR?

The Quality Management System Regulation (QMSR) took effect February 2, 2026 and replaced 21 CFR Part 820 (the Quality System Regulation). The QMSR incorporates ISO 13485:2016 by reference, making it more aligned with the international standard. Key differences remain around FDA-specific reporting requirements, UDI obligations, and 21 CFR Part 11 electronic records requirements. A full breakdown of FDA QSR vs ISO 13485 is here.

How long does it take to get ISO 13485 certified?

For a manufacturer building a QMS from scratch, 12–18 months is a realistic timeline. Organizations with an existing ISO 9001 QMS can often close the gap in 6–12 months, depending on how many medical device-specific requirements need to be added. The ISO 13485 Implementation Roadmap covers the full timeline in detail.

What is a Notified Body and do I need one?

A Notified Body is an organization designated by EU member states to assess conformity of medical devices under the MDR. If you are seeking CE marking for Class IIa, IIb, or Class III devices, you must engage a Notified Body — they conduct the audits that verify ISO 13485 compliance and technical documentation. BSI Group is one of the major Notified Bodies offering both training and certification services.

What are the most common ISO 13485 audit findings?

The most frequently cited areas include: inadequate document and record control (Clause 4.2), incomplete CAPA processes with missing effectiveness verification (Clause 8.5.2), insufficient supplier qualification documentation (Clause 7.4), and gaps in design control records — particularly missing design verification and validation evidence (Clause 7.3). Common mistakes in ISO 13485 QMS implementation covers these in detail.

Do my suppliers need to be ISO 13485 certified?

Not necessarily — but you are responsible for ensuring purchased product meets specifications regardless. Whether a supplier needs ISO 13485 certification depends on their criticality and what they supply. Critical component suppliers and contract manufacturers of finished devices are typically expected to be certified. Commodity suppliers may only require documented incoming inspection.

📥 Free Resources

ISO 13485 Gap Assessment Checklist — free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements — medical device articles only

ISO 9001 Roadmap — step-by-step implementation guide for manufacturers building or improving a quality management system

Manufacturing Compliance Checklist — practical compliance reference covering key ISO, OSHA, and quality requirements for production environments

Supplier Quality Checklist — evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts

AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification

Not Sure What to Do Next?

🔹 Still researching your compliance requirements? Start with a gap assessment against ISO 13485 before you invest in implementation. Download the free ISO 13485 Gap Assessment Checklist — it maps every clause so you know exactly where you stand.

🔹 Ready to build your QMS? ISO 13485 training through BSI Group covers requirements, implementation, and internal auditor training — the right sequence for a team building their first medical device QMS.

🔹 Need the standard itself? Buy ISO 13485:2016 through the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026. International buyers can purchase in multiple languages.

Medical device compliance is not a single standard — it is a framework of interconnected requirements that must be built and maintained as a system. Understanding how ISO 13485, ISO 14971, FDA QMSR, and EU MDR relate to each other is the first step toward building a QMS that holds up under audit. The Standards Navigator covers each of these standards in depth — start with the resources above and build from there.

Stay Current on Medical Device Compliance

Regulatory changes in the medical device space don’t slow down. FDA QMSR took effect in 2026. EU MDR enforcement is intensifying. ISO 14971 continues to be misapplied by manufacturers who treat risk management as a documentation exercise rather than an integrated process.

Organizations that keep pace with these changes have one thing in common — they’re not waiting for an audit finding to tell them something changed. The ones that struggle are managing compliance reactively, updating their QMS only when a customer or inspector forces the issue.

The Standards Navigator covers ISO 13485, ISO 14971, FDA regulatory requirements, and the full medical device compliance framework — from standard purchase through certification and ongoing surveillance.

👉 Get updates when new medical device compliance articles publish
👉 Be first to access the ISO 13485 Documentation Kit when it launches

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

ISO 13485 Implementation Roadmap: How to Build a Compliant Medical Device QMS in 2026

ISO 13485:2016 is now US federal law under the FDA QMSR, making a compliant medical device QMS mandatory rather than optional. This roadmap walks manufacturers through a seven-phase implementation — from gap assessment and scope through risk management, documentation, CAPA, and certification — covering both the international certification path and FDA inspection readiness for US manufacturers building from the ground up.

A step-by-step guide to implementing ISO 13485:2016 — from gap assessment to certification and FDA QMSR readiness

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

Building a Medical Device QMS Is No Longer Optional in the United States

For years, ISO 13485 sat in a strange position for US manufacturers. It was the global benchmark for medical device quality management — required to sell in the EU, Canada, and most of the world — but inside the United States it was voluntary. You complied with FDA’s Quality System Regulation, and ISO 13485 was a nice-to-have for export.

That changed on February 2, 2026. FDA’s Quality Management System Regulation (QMSR) took effect, replacing the old Quality System Regulation and incorporating ISO 13485:2016 by reference directly into 21 CFR Part 820. The practical effect is blunt: ISO 13485:2016 is now part of US federal law. FDA inspections are conducted against it. The standard you could once ignore at home is now the framework your inspector arrives with.

So whether you are a US manufacturer preparing for your first QMSR-aligned FDA inspection, or an international supplier chasing your first ISO 13485 certificate to unlock the EU market, you face the same task: build a quality management system that survives outside scrutiny. This roadmap walks you through it — clause by clause, phase by phase — from the day you decide to start to the day a registrar or an FDA investigator walks through the door.

This ISO 13485 implementation roadmap is a long article because building a medical device QMS is a long project. Use the table of contents to jump to where you are.

Before you build anything, find out where you actually stand. Most teams overestimate how compliant their existing processes are — and discover the gaps during the certification audit or FDA inspection, when fixing them is expensive and the clock is running. Run a clause-by-clause check against ISO 13485:2016 first.

👉 Download the free ISO 13485 Gap Assessment Checklist and benchmark your QMS in an afternoon, before you commit budget to implementation.

In This Guide

Why ISO 13485 implementation looks different in 2026 (QMSR, EU reforms)
The realistic timeline and cost of a full implementation
A seven-phase roadmap from gap assessment to certificate
How risk management (ISO 14971) and design controls fit into the QMS
The documentation you actually need — and where teams over-build
Internal audit, management review, and Stage 1 / Stage 2 audit preparation
FDA QMSR inspection readiness for US manufacturers
The mistakes that fail audits — and how to avoid them

👉 Start Here (Top Resources)

If you are implementing ISO 13485 from scratch, these are the three resources that move the project fastest:

Build your documentation without a consultant. A complete, pre-written ISO 13485 documentation kit gives you the quality manual, procedures, and records templates structured to the standard — so you spend your time tailoring, not drafting from a blank page. 👉 See the ISO 13485 documentation kits at 9001Simplified
Get the official standard. You cannot implement a clause you have not read. Buy ISO 13485:2016 from the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026. ANSI serves international buyers and offers standards in multiple languages.
Train your internal team. Your management representative and internal auditors need formal training. BSI Group offers ISO 13485 training courses spanning awareness through lead auditor.

What Makes 2026 Different

ISO 13485:2016 is still the current edition — and it will be for a while. ISO postponed the next revision deliberately to let the 2016 edition “bed in,” with a new version not expected before roughly 2028–2029. So the standard you implement today is the standard you will operate under for years. That stability is good news: it means your implementation work has a long shelf life.

What has shifted is the regulatory context around the standard.

In the United States, the QMSR is the headline. FDA now incorporates ISO 13485:2016 into 21 CFR Part 820, layered with a handful of FDA-specific additions — labeling, UDI, and certain record and definition provisions — that go beyond the ISO text. A critical nuance: the QMSR is “version locked” to the 2016 edition. Future ISO 13485 revisions will not automatically apply in the US unless FDA initiates new rulemaking. Certification to ISO 13485 is still not legally required in the US — FDA inspects you directly — but building your QMS to the standard is now the most direct path to QMSR compliance.

In the European Union, the pressure point is notified body capacity, not the standard itself. EU Implementing Regulation 2026/977, published in May 2026 and applying from February 25, 2027, finally imposes hard maximum timelines on notified bodies — 30 days to review an application and sign a contract, 120 days for the QMS audit, 90 days for product verification, and 20 days to issue the certificate, with capped clock-stops and transparent quotations. For manufacturers, the message is that the certification path is becoming more predictable, but you still need a clean, audit-ready QMS to take advantage of it.

One more 2026 wrinkle worth flagging if your devices touch biocompatibility: FDA’s recognition of the sixth edition of ISO 10993-1 is partial. Notably, FDA does not recognize Clause 6.9 on biological risk estimation, holding that it conflicts with the recognized risk management standard ISO 14971:2019. If your risk files cite ISO 10993-1 wholesale, that is now a deficiency-letter risk in US submissions. Keep biological risk inside the ISO 14971 framework. We cover biocompatibility in depth separately — for this roadmap, just know that your risk management process is the anchor, not the 10993 series.

If you sell only in the US → build to ISO 13485:2016 for QMSR compliance and skip certification unless a customer demands it. If you sell internationally → you need an actual ISO 13485 certificate from an accredited registrar, so plan for a Stage 1 / Stage 2 audit. If you sell in both markets → build one QMS to ISO 13485:2016 and bolt on the FDA-specific QMSR additions; do not run two parallel systems.

QMSR vs ISO 13485 at a Glance

The two frameworks now share a core, but they are not identical. This is where US and international readers diverge — and where a single well-built QMS can serve both.

Dimension	ISO 13485:2016	FDA QMSR (21 CFR Part 820)
Legal status	Voluntary international standard	Mandatory US federal regulation
Core requirements	The full ISO 13485 QMS	Incorporates ISO 13485:2016 by reference
Proof of compliance	Certificate from accredited registrar	FDA inspection — no certificate issued
Added requirements	None beyond the standard	Labeling, UDI, certain records & definitions
Risk management	References ISO 14971	Requires ISO 14971 framework; rejects ISO 10993-1 Clause 6.9
Version handling	ISO may revise (~2028–2029)	“Version locked” to the 2016 edition
Who needs it	Anyone selling internationally	Any device manufacturer marketing in the US

For the full treatment, see our dedicated FDA QSR vs ISO 13485 comparison.

Timeline and Cost: What to Expect

A realistic ISO 13485 implementation runs 6 to 12 months for a small-to-mid-size manufacturer building from a limited starting point. Companies already operating a mature ISO 9001 system or a legacy QSR-based system can move faster; companies starting from informal processes should plan for the full year.

ISO 13485 implementation timeline infographic showing a phased 6 to 12 month roadmap for medical device manufacturers progressing from gap assessment through certification. — A visual roadmap showing a realistic ISO 13485 implementation timeline from assessment through certification readiness.

Phase	Typical duration	What drives it
Gap assessment & scope	2–4 weeks	Size of the gap between current practice and the standard
Process & documentation build	8–16 weeks	Whether you draft from scratch or start from templates
Implementation & operation	8–12 weeks	You need real records, not just documents — audits want evidence
Internal audit & management review	3–4 weeks	Must be complete before a registrar will proceed to Stage 2
Certification (Stage 1 + Stage 2)	6–10 weeks	Registrar scheduling and any nonconformity closure

On cost, the single biggest variable is whether you hire a consultant to draft your system or build it yourself from a structured template. Consultant-led implementations commonly run $15,000–$50,000+ depending on device class and company size. A template-driven build can cut the documentation labor dramatically. For a full breakdown, see our guide on how much ISO 13485 certification costs.

Phase 1 — Foundation: Scope, Standard, and Leadership Commitment

Everything downstream depends on getting three things right at the start.

Define your QMS scope. ISO 13485 lets you exclude certain requirements — for example, design and development (Clause 7.3) if you are a contract manufacturer building to a customer’s design. But exclusions must be justified and documented, and you cannot exclude something just because it is inconvenient. Map which clauses apply to your role: manufacturer, specification developer, contract manufacturer, sterilization provider, or importer. Your scope statement is the first thing a registrar reads and the boundary an FDA investigator works within.

Acquire and read the standard. This sounds obvious and gets skipped constantly. You cannot delegate compliance with a document nobody on the team has read end to end. Buy the official ISO 13485:2016 text from the ANSI Webstore — apply coupon CC2026 for 5% off through the end of 2026 — and have your management representative work through it clause by clause. If you also need the risk management standard, ISO 14971:2019 is available there too. ANSI’s catalog covers international buyers and multiple languages, which matters if your QMS spans sites.

Secure genuine leadership commitment. Clause 5 puts top management on the hook — quality policy, quality objectives, resource allocation, and management review are not delegable to a quality manager working in isolation. The fastest implementations have an executive sponsor who clears roadblocks. The ones that stall have a quality team trying to impose a system the leadership treats as paperwork.

If you are a contract manufacturer → document your design and development exclusion now, with justification, before you build the rest of the system around it.

⚠️ Common pitfall: Claiming a Clause 7.3 exclusion you can’t defend. If your team does any design input — even tweaking a customer’s spec for manufacturability — a registrar may reject the exclusion and you’ll be retrofitting design controls mid-project. Decide your true scope honestly before you build.

Most ISO 13485 projects don’t fail on the standard — they fail on documentation that nobody can find, follow, or defend in an audit. Before you write a single procedure, make sure you know which records the standard actually requires.

👉 Run the gap assessment and map your existing documents against the clauses — it turns “we think we’re covered” into a defensible list.

Phase 2 — Plan: Processes, Roles, and Competence

ISO 13485 is a process-based standard. Before documentation, map your actual processes and how they connect — the “sequence and interaction” the standard requires.

Identify your core processes. At minimum: management processes (planning, review, resourcing), product realization (design, purchasing, production, servicing), and support processes (document control, records, CAPA, internal audit). For each, define inputs, outputs, owners, and the records that prove it ran.

Appoint a management representative. Clause 5.5.2 requires a member of management responsible for the QMS. This person owns the system, reports its performance to leadership, and is typically the registrar’s main point of contact.

Plan competence and training. Clause 6.2 requires that personnel performing work affecting product quality are competent — with records to prove it. This includes your internal auditors, who must be trained and independent of the areas they audit. Formal training shortens the learning curve here; BSI Group’s ISO 13485 course catalog runs from awareness through lead auditor, and the lead-auditor tier is what equips your internal audit program to find problems before the registrar does. For audit methodology itself, note that the underlying guidance standard, ISO 19011, was updated to a 2026 edition in May 2026 — worth referencing when you write your internal audit procedure.

⚠️ Common pitfall: Treating internal auditor “independence” as a formality. Having someone audit their own department is one of the most common nonconformities — and it quietly undermines every finding that audit produces. Cross-train auditors so no one reviews work they own.

Phase 3 — Risk Management and Design Controls

This is where ISO 13485 separates itself from ISO 9001, and where the most consequential implementation decisions live.

Risk management is the spine. ISO 13485 threads risk-based thinking through the entire product lifecycle, and it leans on ISO 14971:2019 as the method. You need a risk management process, a risk management file for each device or device family, and evidence that risk controls are verified and monitored in production and post-market. As noted earlier, keep biological risk inside this ISO 14971 framework rather than importing a separate scoring approach — that alignment is exactly what FDA expects under the QMSR.

Design controls (Clause 7.3) apply if you develop devices. This is the discipline FDA investigators scrutinize hardest, because design failures are where patients get hurt. You need:

Design control element	What it requires
Design and development planning	A documented plan with stages, reviews, and responsibilities
Design inputs	Requirements derived from intended use, user needs, and regulation
Design outputs	Specifications that can be verified against inputs
Design review	Formal reviews at planned stages with independent reviewers
Design verification	Evidence outputs meet inputs
Design validation	Evidence the device meets user needs in actual or simulated use
Design transfer	Controlled handoff to production
Design changes	Controlled, reviewed, and documented changes
Design history file (DHF)	The complete record of the above

If you are a US manufacturer, the QMSR keeps design controls firmly in play — they map directly onto the ISO 13485 Clause 7.3 requirements, which is one reason a single ISO-aligned system now serves both purposes.

If you are preparing your first device submission → build the risk management file and design history file in parallel with the QMS, not after. Auditors and investigators expect to see them populated, not planned.

⚠️ Common pitfall: Building the risk file as a one-time document for the submission, then never touching it again. Risk management is a living, lifecycle requirement — production and post-market data have to feed back into it. A risk file frozen at launch is a finding waiting to happen.

Phase 4 — Build the Documentation

Now you write the system. ISO 13485 expects a defined documentation hierarchy: a quality manual, documented procedures, work instructions, forms, and the records they generate.

ISO 13485 documentation architecture infographic showing the five-layer quality management documentation hierarchy from quality manual through records. — A visual breakdown of the five documentation layers used to build and maintain an ISO 13485 quality management system.

The required documents. ISO 13485:2016 explicitly requires certain documented procedures — document control, record control, management review, internal audit, control of nonconforming product, CAPA, and several product-realization procedures among them. A medical device file (technical documentation) is required for each device type. Our breakdown of ISO 13485 documentation requirements lists exactly what the standard mandates versus what is optional.

Where teams over-build. The most common documentation mistake is writing procedures more detailed and rigid than the operation can actually follow. Every sentence in a procedure is a commitment an auditor can hold you to. If your procedure says calibration happens every 90 days and a record shows 95, that is a nonconformity you created with your own words. Write to what you do; improve what you do separately.

Start from a structured template, not a blank page. Drafting an entire ISO 13485 documentation set from scratch is where 6-month projects become 12-month projects. A complete documentation kit gives you the quality manual, every required procedure, and the records templates already structured to the clauses — so your team spends its hours tailoring language to your operation instead of reinventing the architecture of a QMS.

👉 See what’s included in the 9001Simplified ISO 13485 documentation kit — it is the no-consultant route most small manufacturers should evaluate first.

Set up document and record control before you generate volume. Clauses 4.2.4 and 4.2.5 require controlled documents and controlled records. Get the control mechanism — versioning, approval, retention, retrieval — working before you have hundreds of documents to retrofit.

⚠️ Common pitfall: Over-documenting. Teams write procedures so detailed and rigid that the floor can’t actually follow them — then every deviation from their own paperwork becomes a nonconformity. Document what you genuinely do, keep procedures lean, and push the specifics down into work instructions where they’re easier to change.

Phase 5 — Implement and Operate

A documented QMS proves nothing. Auditors and investigators want records that show the system ran.

This is the phase teams underestimate. You can write a CAPA procedure in a day; demonstrating that CAPA actually works requires real CAPAs opened, investigated, and closed over weeks. Plan for an operating period — typically 8 to 12 weeks minimum — where the system runs and generates genuine evidence: training records, calibration records, completed reviews, supplier evaluations, nonconformance reports, and CAPA records.

A registrar will not progress to a certification audit, and an FDA investigator will not be satisfied, by documents alone. Both want to trace a process from requirement to record to outcome. Build that evidence trail before you invite anyone to inspect it.

If you are under customer pressure to certify quickly → start operating the system in parallel with finishing documentation, so your evidence trail is already accumulating when the documents are signed off.

⚠️ Common pitfall: Booking the certification audit before the system has actually run. A registrar can tell the difference between a QMS that has operated for three months and one that generated all its records last week. Backdated or thin evidence is the fastest way to turn a Stage 2 audit into a list of nonconformities.

Phase 6 — CAPA, Supplier Controls, and Production Controls

Three areas generate the most audit findings and FDA 483 observations. Get them right and you de-risk the entire certification.

CAPA (Corrective and Preventive Action). This is the single most-cited area in medical device QMS audits. A weak CAPA system — actions opened and never closed, root causes not actually identified, effectiveness never verified — signals to an auditor that the whole system is decorative. Your CAPA process must show genuine root cause analysis, defined actions, and verified effectiveness. Our deep dive on CAPA requirements in ISO 13485 covers the failure modes in detail.

Supplier and purchasing controls (Clause 7.4). You are accountable for what your suppliers provide. You need defined supplier evaluation criteria, approved-supplier records, and controls proportionate to the risk the purchased product carries. Flow your quality requirements down in writing — handshake arrangements do not survive audits.

Production and process controls (Clauses 7.5). This includes process validation for any process whose output cannot be fully verified by later inspection — sterilization and certain welding or molding processes are classic examples — plus identification, traceability, and handling of product. Cleanliness, contamination control, and installation/servicing requirements apply where relevant to your device.

A documentation kit accelerates this layer too. The CAPA log, supplier evaluation forms, nonconformance records, and validation templates are exactly the high-stakes documents you do not want to invent under deadline.

👉 A structured kit gives you defensible templates for all three areas so your effort goes into running the processes, not formatting the paperwork.

Avoid the recurring traps documented in our guide to common mistakes in ISO 13485 QMS implementation — most failures are predictable.

⚠️ Common pitfall: Closing CAPAs without verifying effectiveness. “We retrained the operator” is not a closed CAPA — it’s an action with no proof it worked. Auditors reopen these constantly. Every CAPA needs a defined effectiveness check and evidence it passed before you close it.

Phase 7 — Internal Audit, Management Review, and Certification

Before any external party inspects you, inspect yourself.

Internal audit (Clause 8.2.4). Conduct a full internal audit of your QMS against ISO 13485 using trained, independent auditors. This is your dress rehearsal — the audit that finds problems while you still control the timeline and the narrative. Document findings, open CAPAs, and close them.

Management review (Clause 5.6). Top management formally reviews QMS performance against defined inputs — audit results, customer feedback, process performance, CAPA status, and more — and produces documented outputs and decisions. Registrars treat a missing or hollow management review as a serious gap.

The certification audit (international path). An accredited registrar conducts a two-stage audit:

Stage	Focus	Outcome
Stage 1	Documentation review and readiness	Confirms the system is ready for Stage 2; identifies gaps
Stage 2	On-site implementation audit	Verifies the system operates as documented; raises any nonconformities

Close any nonconformities, and the registrar issues your certificate — typically valid for three years with annual surveillance audits. Choosing an accredited registrar matters; verify accreditation through bodies like ANAB or the relevant IAF member. Our guide to the best ISO certification bodies walks through selection.

⚠️ Common pitfall: Running a hollow management review to check the box. A review that doesn’t actually examine audit results, CAPA status, and process performance — and produce real decisions — is treated by registrars as a serious gap, because it signals leadership isn’t engaged. Make it substantive, and keep the minutes.

FDA QMSR Inspection Readiness

If you are a US manufacturer, your “certification audit” may instead be an FDA inspection — and the bar is the QMSR, which now runs on ISO 13485:2016 plus FDA’s additions.

Practical readiness steps:

Map ISO 13485 to the QMSR additions. Most of your ISO-aligned system satisfies Part 820 directly. Layer in the FDA-specific requirements — labeling and packaging controls, UDI, and certain record and complaint-handling provisions — that exceed the ISO text.
Keep your records inspection-ready, not audit-ready-once. FDA inspections are unannounced or short-notice. The evidence trail from Phase 5 has to be standing, not assembled on demand.
Treat CAPA and complaint handling as the focal points. These are where 483 observations concentrate. A clean, closed-loop CAPA system is your strongest signal of control.
Understand the relationship between the two frameworks. Our comparison of FDA QSR vs ISO 13485 explains exactly what the QMSR changed and where the frameworks now align.

For US manufacturers selling internationally, the efficient move is one ISO 13485 QMS with the QMSR additions built in — not two systems. The frameworks now overlap by design.

Quick Implementation Checklist

Use this as a high-level progress tracker. Each item maps to a phase above.

✅ QMS scope defined and exclusions justified in writing
✅ Official ISO 13485:2016 (and ISO 14971:2019) acquired and read
✅ Top management commitment secured; quality policy and objectives set
✅ Management representative appointed
✅ Core processes mapped with owners, inputs, outputs, and records
✅ Personnel competence and internal auditor training in place
✅ Risk management process and risk management file established (ISO 14971)
✅ Design controls and design history file in place (if you develop devices)
✅ Quality manual, required procedures, and record templates written
✅ Document control and record control operating before volume builds
✅ System operated long enough to generate genuine records (8–12 weeks)
✅ CAPA system demonstrably closing the loop with verified effectiveness
✅ Supplier evaluation and purchasing controls documented and flowed down
✅ Process validation completed where output can’t be fully verified
✅ Full internal audit completed; findings closed
✅ Management review conducted with documented outputs
✅ Registrar selected (international) or QMSR inspection readiness confirmed (US)
✅ Stage 1 and Stage 2 audit passed; nonconformities closed

FAQ

How long does ISO 13485 implementation take?

For a small-to-mid-size manufacturer building from a limited starting point, plan for 6 to 12 months. Companies with a mature ISO 9001 system or a legacy QSR-based system can move faster, while organizations starting from informal processes should plan for the full year. The longest single phase is usually documentation, followed by the operating period needed to generate real records.

Is ISO 13485 certification required in the United States?

No. FDA inspects US manufacturers directly against the QMSR, which incorporates ISO 13485:2016 — certification by a third-party registrar is not legally required. However, building your QMS to ISO 13485 is now the most direct path to QMSR compliance, and certification is required to sell in the EU, Canada, and most international markets. Many US manufacturers certify anyway to serve global customers and demonstrate a recognized standard of control.

What is the difference between ISO 13485 and the FDA QMSR?

The QMSR, effective February 2, 2026, replaced FDA’s old Quality System Regulation and incorporates ISO 13485:2016 by reference into 21 CFR Part 820, plus FDA-specific additions covering labeling, UDI, and certain records. The two are now largely aligned by design. The QMSR is “version locked” to the 2016 edition, so future ISO 13485 revisions will not automatically apply in the US. See our full FDA QSR vs ISO 13485 comparison for detail.

Do I need ISO 14971 to implement ISO 13485?

Effectively, yes. ISO 13485 threads risk-based thinking through the product lifecycle and relies on the methodology in ISO 14971:2019 for risk management. You need a documented risk management process and a risk management file for each device. We explain the relationship in ISO 14971 vs ISO 13485.

Can a contract manufacturer exclude design controls?

Yes, if you build strictly to a customer’s design and do not perform design and development activities. ISO 13485 permits excluding Clause 7.3, but the exclusion must be justified and documented in your QMS scope. You cannot exclude a requirement simply because it is burdensome — only because it genuinely does not apply to your role.

What causes most ISO 13485 audit findings?

CAPA weaknesses lead the list — actions that never close, root causes not genuinely identified, and effectiveness never verified. Document and record control, supplier controls, and process validation are also frequent finding areas. Our guide to common ISO 13485 QMS mistakes covers the recurring patterns.

Should I hire a consultant or use a documentation kit?

It depends on device class, internal capacity, and budget. Consultant-led implementations offer hands-on guidance but commonly run $15,000–$50,000 or more. A structured documentation kit gives you the full QMS architecture — manual, procedures, and record templates — at a fraction of that cost, so your team tailors rather than drafts from scratch. Many small manufacturers start with a kit and bring in targeted consulting only for device-specific risk and design questions.

What is ISO 13485 and who needs it?

ISO 13485 is the international quality management system standard for organizations involved in the medical device lifecycle — design, production, storage, distribution, installation, and servicing. It applies to manufacturers, specification developers, contract manufacturers, sterilization providers, and importers. Our primer, What Is ISO 13485?, covers the fundamentals.

📥 Free Resources

Practical tools to support your implementation — download what fits your project:

ISO 13485 Gap Assessment Checklist — free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements, clause by clause, before committing to implementation.
ISO 9001 Roadmap — step-by-step implementation guide for organizations building or improving a quality management system, useful if you operate an ISO 9001 base alongside 13485.
Manufacturing Compliance Checklist — practical compliance reference covering key ISO, OSHA, and quality requirements for production environments.
Supplier Quality Checklist — evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts.
AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification, for teams operating across aerospace and medical device lines.

Not Sure What to Do Next?

Your next step depends on where you are in the project:

🔹 If you haven’t assessed your gap yet → start with the free ISO 13485 Gap Assessment Checklist. Don’t commit budget to implementation until you know the size of the gap.
🔹 If you’re ready to build documentation → evaluate a complete ISO 13485 documentation kit before paying consultant rates to draft from scratch. It is the fastest route to an audit-ready document set for most small manufacturers.
🔹 If you’re comparing the US and international paths → read FDA QSR vs ISO 13485 and how much ISO 13485 costs to scope budget and timeline before you choose.

Building an ISO 13485 QMS is a real project, but it is a known one. The clauses are fixed, the phases are sequential, and the failure modes are predictable. Move through it in order, build real evidence as you go, and inspect yourself before anyone else does — and a certification audit or FDA inspection becomes a confirmation, not a gamble. The Standards Navigator exists to make exactly this kind of industrial compliance work clear and survivable for the people who have to actually do it.

Most teams don’t fail ISO 13485 because they misunderstand the standard — they fail because they assumed they were compliant and found out during the audit. The organizations that struggle treat the QMS as paperwork to satisfy a registrar. The organizations that succeed treat it as the operating system that proves their devices are safe — and they build evidence from day one.

The Standards Navigator covers medical device compliance from QMSR readiness to risk management, CAPA, and certification — written from operational and quality management experience, not generic theory.

👉 Get updates on medical device QMS, ISO 13485, and FDA QMSR compliance
👉 Be first to access new gap assessment tools, documentation guides, and implementation resources

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

The Internal Audit That Used to Be Private Isn’t Anymore

In This Guide

Table of Contents

👉 Start Here (Top Resources)

What Clause 8.2.4 Actually Requires

Internal Audits vs. Supplier Audits vs. Certification Audits

Auditor Competence: What Clause 6.2 Actually Requires

Building a Risk-Based Audit Program

The Internal Audit Process, Step by Step

A Real Finding, Start to Finish

The Five Most Common Findings

MDSAP: What Changes for Multi-Market Audits

What Changed: QMSR and ISO 19011:2026

Quick Audit-Readiness Checklist

FAQ

How often does ISO 13485 require internal audits?

Can the same person who performs a process also audit it?

Do internal auditors need a formal certification?

Does the FDA QMSR require a separate internal audit program from ISO 13485?

Are internal audit reports confidential from FDA inspectors?

What’s the difference between an internal audit and a supplier audit under ISO 13485?

Does MDSAP replace our ISO 13485 internal audit requirement?

What’s the most common reason internal audit programs fail a certification audit?

Should we hire a consultant to run our internal audits, or can we do it ourselves?

📥 Free Resources

Not Sure What to Do Next?

Subscribe for Medical Device Compliance Updates

Subscribe

The Compliance Gap That Gets Medical Device Manufacturers in Trouble

Table of Contents

The Core Standard: ISO 13485:2016

Risk Management: ISO 14971:2019

US Regulatory Requirements: FDA QMSR and 21 CFR Part 820

EU Requirements: MDR and CE Marking

Supplier Controls and Special Process Standards

Design Controls and Validation Standards

Labeling and Traceability Standards

How the Standards Work Together

Quick Compliance Checklist

FAQ

Is ISO 13485 certification required to sell medical devices?

How is ISO 13485 different from ISO 9001?

Do I need ISO 14971 if I am ISO 13485 certified?

What is the FDA QMSR and how is it different from the old QSR?

How long does it take to get ISO 13485 certified?

What is a Notified Body and do I need one?

What are the most common ISO 13485 audit findings?

Do my suppliers need to be ISO 13485 certified?

📥 Free Resources

Not Sure What to Do Next?

Stay Current on Medical Device Compliance

Subscribe

Building a Medical Device QMS Is No Longer Optional in the United States

In This Guide

Table of Contents

👉 Start Here (Top Resources)

What Makes 2026 Different

QMSR vs ISO 13485 at a Glance

Timeline and Cost: What to Expect

Phase 1 — Foundation: Scope, Standard, and Leadership Commitment

Phase 2 — Plan: Processes, Roles, and Competence

Phase 3 — Risk Management and Design Controls

Phase 4 — Build the Documentation

Phase 5 — Implement and Operate

Phase 6 — CAPA, Supplier Controls, and Production Controls

Phase 7 — Internal Audit, Management Review, and Certification

FDA QMSR Inspection Readiness

Quick Implementation Checklist

FAQ

How long does ISO 13485 implementation take?

Is ISO 13485 certification required in the United States?

What is the difference between ISO 13485 and the FDA QMSR?

Do I need ISO 14971 to implement ISO 13485?

Can a contract manufacturer exclude design controls?

What causes most ISO 13485 audit findings?

Should I hire a consultant or use a documentation kit?

What is ISO 13485 and who needs it?

📥 Free Resources

Not Sure What to Do Next?

Subscribe